INFLUENCE OF DOSAGE FORM ON PAPAVERINE BIOAVAILABILITY

被引：8
|
作者：
MEYER, MC [1 ]
GOLLAMUDI, R [1 ]
STRAUGHN, AB [1 ]
机构：
[1] UNIV TENNESSEE,CTR HLTH SCI,COLL PHARM,DEPT MED CHEM,MEMPHIS,TN 38163
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 1979年 / 19卷 / 8-9期
关键词：
D O I：
10.1002/j.1552-4604.1979.tb02505.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：435 / 444
页数：10
相关论文
共 50 条
  • [21] INFLUENCE OF DOSAGE FORM ON ACTIVITY OF A DIURETIC AGENT
    TANNENBAUM, PJ
    ROSEN, E
    FLANAGAN, T
    CROSLEY, AP
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1968, 9 (05) : 598 - +
  • [22] Influence of Dosage Form on the Intravitreal Pharmacokinetics of Diclofenac
    Durairaj, Chandrasekar
    Kim, Stephen J.
    Edelhauser, Henry F.
    Shah, Jaymin C.
    Kompella, Uday B.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2009, 50 (10) : 4887 - 4897
  • [23] Gastro-retentive dosage form for improving bioavailability of Cefpodoxime proxetil in rats
    Kakumanu, Vasu Kumar
    Arora, Vinod Kumar
    Bansal, Arvind Kumar
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2008, 128 (03): : 439 - 445
  • [24] Interplay of dosage form and nutrient properties in the bioavailability of micronutrients prophylactic for eye disease
    Lang, John C.
    Johnson, Elizabeth J.
    Vishwanathan, Rohini
    Rasmussen, Helen M.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
  • [25] A SIMPLE PHOTOMETRIC ASSAY OF PAPAVERINE IN DOSAGE FORMS
    KARAWYA, MS
    DIAB, AM
    SWELEM, NZ
    ANALYTICAL LETTERS PART B-CLINICAL AND BIOCHEMICAL ANALYSIS, 1984, 17 (01): : 69 - 75
  • [26] SERUM AMPICILLIN LEVELS IN CALF - INFLUENCE OF DOSAGE, ROUTE OF ADMINISTRATION AND DOSAGE FORM
    BLACK, WD
    CANADIAN JOURNAL OF COMPARATIVE MEDICINE-REVUE CANADIENNE DE MEDECINE COMPAREE, 1976, 40 (04): : 341 - 345
  • [27] The influence of dissolved phosphorus molecular form on recalcitrance and bioavailability
    Li, Bo
    Brett, Michael T.
    ENVIRONMENTAL POLLUTION, 2013, 182 : 37 - 44
  • [28] DOSAGE FORM DESIGN FOR IMPROVEMENT OF BIOAVAILABILITY OF LEVODOPA-IV - POSSIBLE CAUSES OF LOW BIOAVAILABILITY OF ORAL LEVODOPA IN DOGS
    SASAHARA, K
    NITANAI, T
    HABARA, T
    KOJIMA, T
    KAWAHARA, Y
    MORIOKA, T
    NAKAJIMA, E
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1981, 70 (07) : 730 - 733
  • [29] Inclusion compound: a preferable dosage form to enhance bioavailability of astragaloside IV in intact rat
    Yu, Junxian
    Zhang, Yindi
    Sun, Shi
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 226 - 226
  • [30] A new oral dosage form of topotecan: Bioavailability and effect of food co-administration
    Herben, VMM
    Schellens, JHM
    Huinink, WWT
    Rosing, H
    van Zomeren, DM
    Beusenberg, FB
    Ross, G
    Beijnen, JH
    ANNALS OF ONCOLOGY, 1998, 9 : 60 - 60
12345